Merrimack Pharmaceuticals Inc - Company Profile
Powered by 
All the data and insights you need on Merrimack Pharmaceuticals Inc in one report.
$295
- Save hours of research time and resources with
our up-to-date Merrimack Pharmaceuticals Inc Strategy Report
- Understand Merrimack Pharmaceuticals Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Get in touch about GlobalData Company reports
Contact the team or request a demo to find out how our data can drive your business forward
Merrimack Pharmaceuticals Inc (Merrimack) is a clinical-stage biopharmaceutical company that develops and commercializes novel targeted solutions for the treatment of various types of cancers through its understanding of biological markers and cancer pathways. Its first commercial product, Onivyde (irinotecan liposome injection), is a liposomal formulation for the treatment of advanced pancreatic cancer patients. Merrimack is headquartered in Cambridge, Massachusetts, the US.
Headquarters
United States of America
Address
One Broadway, 14th Floor, Cambridge, Massachusetts, 02142
Website
www.merrimack.com
Telephone
1 617 4411000
Industry
Pharmaceuticals and Healthcare
Ticker Symbol & Exchange
MACK (NASD)
EPS
XYZ
Net Income (2022)
XYZ
23.5%
(2022 vs 2021)
Market Cap*
$218.4M
Net Profit Margin (0 vs)
XYZ
0.0%
(2022 vs 2021)
* As of and is in US$
Merrimack Pharmaceuticals Inc premium industry data and analytics
Products and Services
| Products |
|---|
| Legacy products: |
| MM-121 |
| MM-111 |
| XYZ |
| XYZ |
| XYZ |
Competitor Comparison
| Key Parameters | Merrimack Pharmaceuticals Inc | Athenex Inc | Dare Bioscience Inc | Cephalon Inc | Hengrui Therapeutics Inc |
|---|---|---|---|---|---|
| Headquarters | United States of America | United States of America | United States of America | United States of America | United States of America |
| City | Cambridge | Buffalo | San Diego | North Wales | Princeton |
| State/Province | Massachusetts | New York | California | Pennsylvania | New Jersey |
| No. of Employees | - | 269 | 25 | - | - |
| Entity Type | Public | Private | Public | Private | Private |
Key Financial Charts
Sales Growth
Net Income Growth
Executives
| Name | Position | Board | Since | Age |
|---|---|---|---|---|
| Gary L. Crocker | Treasurer; President; Chairman | Executive Board | 2019 | 71 |
| Ulrik B. Nielsen | Director | Non Executive Board | 2015 | 51 |
| Ana Radeljevic | Director | Non Executive Board | 2022 | 43 |
| Eric D. Andersen | Director | Non Executive Board | 2019 | 45 |
| Noah G. Levy | Director | Non Executive Board | 2019 | 45 |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
| Non Dignissim Eros | Proin vel | Convallis | 2024 | XY |
Still looking?
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Explorer
Access more premium companies when you subscribe to Explorer